Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals
Open Access
- 14 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e39368
Abstract
We have previously reported a world-first phase I clinical trial to treat HCV patients using monocyte-derived dendritic cells (Mo-DC) loaded with HCV-specific lipopeptides. While the brief treatment proved to be safe, it failed to reduce the viral load and induced only transient cell-mediated immune responses, measured by IFNγ ELIspot. Here we reanalysed the PBMC samples from this trial to further elucidate the immunological events associated with the Mo-DC therapy. We found that HCV-specific single- and multi-cytokine secreting T cells were induced by the Mo-DC immunotherapy in some patients, although at irregular intervals and not consistently directed to the same HCV antigen. Despite the vaccination, the responses were generally poor in quality and comprised of primarily single-cytokine secreting cells. The frequency of FOXP3+ regulatory T cells (Treg) fluctuated following DC infusion and eventually dropped to below baseline by week 12, an interesting trend suggesting that the vaccination may have resulted in a more subtle outcome than was initially apparent. Our data suggested that Mo-DC therapy induced complex immune responses in vivo that may or may not lead to clinical benefit.Keywords
This publication has 18 references indexed in Scilit:
- Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccinesImmunology & Cell Biology, 2011
- A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsJournal of Hepatology, 2010
- Analysis of FOXP3+ Regulatory T Cells That Display Apparent Viral Antigen Specificity during Chronic Hepatitis C Virus InfectionPLOS Pathogens, 2009
- Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen‐specific T cells without the addition of exogenous maturation factorsJournal of Viral Hepatitis, 2008
- T-cell quality in memory and protection: implications for vaccine designNature Reviews Immunology, 2008
- Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing CellsJournal of Virology, 2007
- Defining target antigens for CD25+FOXP3+IFN‐γ− regulatory T cells in chronic hepatitis C virus infectionImmunology & Cell Biology, 2007
- Intracellular cytokine optimization and standard operating procedureNature Protocols, 2006
- HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cellsBlood, 2006
- A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJournal of Immunological Methods, 2002